Načítá se...
Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization
Atherogenic dyslipidemia, including low HDL levels, is the major contributor of residual risk of cardiovascular disease that remains even after aggressive statin therapy to reduce LDL-cholesterol. Currently, distinction is not made between HDL-cholesterol and HDL, which is a lipoprotein consisting o...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3098044/ https://ncbi.nlm.nih.gov/pubmed/21438812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erc.11.16 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|